CDP Choline (Citicoline) Powder

CDP Choline (Citicoline) Powder

Introduction

CDP Choline Powder, also known as Citicoline, is a research compound gaining recognition in the scientific community for its potential applications in various research areas. This product is strictly for research purposes, with no reference to human consumption. Researchers study CDP Choline’s properties and its impact on cognition and neural function, making it valuable for neuroscience research.

Key Characteristics

CDP Choline Powder is notable for its role in neural pathways, primarily as a precursor to acetylcholine. This compound plays a role in cholinergic transmission, synaptic membrane formation, and neural membrane integrity. Its distinct mechanisms make it an intriguing focus of research in neuroscience and cognitive studies.

Research Applications

CDP Choline’s properties make it a compelling subject for research. Researchers have been drawn to this compound for its potential applications in the following fields:

Research Benefits

Cognitive Enhancement

Studies suggest that CDP Choline may support cognitive function. It has been investigated for its potential to improve memory, learning capacity, and overall cognitive performance. This makes it a valuable asset in cognitive and neuroscience research.

Neuroprotection

CDP Choline has been linked to neuroprotective effects. Research suggests it may support neural tissue health. This aspect is of significant interest to studies related to neurodegenerative conditions and brain health.

Stroke Recovery

Studies have examined CDP Choline’s potential role in stroke recovery. Research indicates that it may contribute to post-stroke rehabilitation by aiding in cognitive and motor function recovery.

Summary

CDP Choline Powder has potential applications in cognitive enhancement, neuroprotection, and stroke recovery. Researchers in the fields of neuroscience, psychology, and neurology find CDP Choline a valuable subject for investigation. CDP Choline is strictly for research purposes, with no mention of human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions.  Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

(1) Lozano Fernández R. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases. Arzneimittelforschung. 1983;33(7A):1073-80. PMID: 6684470. [Read More]

(2) Secades JJ, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Martínez-Vila E, Ríos J, Oudovenko N. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials. J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1984-96. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.010. Epub 2016 May 24. PMID: 27234918. [Read More]

(3) Lozano Fernández R. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases. Arzneimittelforschung. 1983;33(7A):1073-80. PMID: 6684470. [Read More]